131 related articles for article (PubMed ID: 1544607)
1. Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C]pyrrolidinone in the rat.
Midgley I; Hood AJ; Chasseaud LF; Brindley CJ; Baughman S; Allan G
Food Chem Toxicol; 1992 Jan; 30(1):57-64. PubMed ID: 1544607
[TBL] [Abstract][Full Text] [Related]
2. Disposition and metabolism of double-labeled [3H and 14C] N-methyl-2-pyrrolidinone in the rat.
Wells DA; Digenis GA
Drug Metab Dispos; 1988; 16(2):243-9. PubMed ID: 2898341
[TBL] [Abstract][Full Text] [Related]
3. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
4. Absorption, metabolism, and disposition of [14C]SDZ ENA 713, an acetylcholinesterase inhibitor, in minipigs following oral, intravenous, and dermal administration.
Tse FL; Laplanche R
Pharm Res; 1998 Oct; 15(10):1614-20. PubMed ID: 9794506
[TBL] [Abstract][Full Text] [Related]
5. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
Ligocka D; Lison D; Haufroid V
Arch Toxicol; 2003 May; 77(5):261-6. PubMed ID: 12734639
[TBL] [Abstract][Full Text] [Related]
6. Age-related percutaneous penetration of 2-sec-butyl-4,6-dinitrophenol (dinoseb) in rats.
Hall LL; Fisher HL; Sumler MR; Hughes MF; Shah PV
Fundam Appl Toxicol; 1992 Aug; 19(2):258-67. PubMed ID: 1516783
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous absorption of 14C-labelled 2-chlorobenzaldehyde in rats. Metabolism and toxicokinetics.
Rietveld EC; Hoet RM; Seutter-Berlage F; Van Rossum JM
Eur J Drug Metab Pharmacokinet; 1988; 13(4):231-40. PubMed ID: 3243317
[TBL] [Abstract][Full Text] [Related]
8. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of 2-ethyl-1,3-hexanediol. II. Nonsystemic disposition following single percutaneous or peroral doses in Fischer 344 rats.
Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Ballantyne B
Drug Metab Dispos; 1992; 20(1):6-18. PubMed ID: 1346998
[TBL] [Abstract][Full Text] [Related]
10. Absorption and disposition of 14C-labelled Kathon biocide, a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one, following intravenous or dermal administration to male Sprague-Dawley rats.
deBethizy JD; Longacre SL; Steigerwalt RB; Deckert FW; Moss JN; Hayes AW; Smith JM; Scribner HE
Food Chem Toxicol; 1986 Jan; 24(1):43-9. PubMed ID: 3949268
[TBL] [Abstract][Full Text] [Related]
11. 4,4'-methylene-bis-ortho-chloro-aniline (MBOCA): absorption and excretion after skin application and gavage.
Groth DH; Weigel WW; Tolos WP; Brewer DE; Cheever KL; Burg JR
Environ Res; 1984 Jun; 34(1):38-54. PubMed ID: 6723608
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution and excretion of N-methyl-2-pyrrolidone in male and female rats.
Sitarek K; Kilanowicz A
Int J Occup Med Environ Health; 2006; 19(2):142-8. PubMed ID: 17128812
[TBL] [Abstract][Full Text] [Related]
13. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
14. Studies on benzyl acetate. III. The percutaneous absorption and disposition of [methylene-14C]benzyl acetate in the rat.
Chidgey MA; Kennedy JF; Caldwell J
Food Chem Toxicol; 1987 Jul; 25(7):521-5. PubMed ID: 3623341
[TBL] [Abstract][Full Text] [Related]
15. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester.
Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G
Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486
[TBL] [Abstract][Full Text] [Related]
16. Toxicokinetics and metabolism of N-[(14)C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: in vivo and in vitro percutaneous absorption.
Payan JP; Boudry I; Beydon D; Fabry JP; Grandclaude MC; Ferrari E; André JC
Drug Metab Dispos; 2003 May; 31(5):659-69. PubMed ID: 12695356
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and disposition of hydroquinone in Fischer 344 rats after oral or dermal administration.
English JC; Deisinger PJ
Food Chem Toxicol; 2005 Mar; 43(3):483-93. PubMed ID: 15680685
[TBL] [Abstract][Full Text] [Related]
18. Oral absorption, metabolism and excretion of 1-phenoxy-2-propanol in rats.
Saghir SA; Brzak KA; Bartels MJ
Xenobiotica; 2003 Oct; 33(10):1059-71. PubMed ID: 14555341
[TBL] [Abstract][Full Text] [Related]
19. Disposition of N-vinyl-2-pyrrolidinone in the rat.
McClanahan JS; Lin YC; Digenis GA
Drug Chem Toxicol; 1984; 7(2):129-48. PubMed ID: 6434280
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
